We are live on ! Find out more
TFP

Triune Financial Partners Portfolio holdings

AUM $421M
1-Year Est. Return 22.09%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+22.09%
3 Year Est. Return
+50.64%
5 Year Est. Return
10 Year Est. Return
AUM
$269M
AUM Growth
+$26.8M
Cap. Flow
+$1.91M
Cap. Flow %
0.71%
Top 10 Hldgs %
96.62%
Holding
35
New
3
Increased
17
Reduced
10
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 1%
2 Energy 0.38%
3 Healthcare 0.35%
4 Technology 0.25%
5 Industrials 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
26
Vanguard S&P 500 ETF
VOO
$979B
$281K 0.1%
643
-194
-23% -$79.4K
DHR icon
27
Danaher
DHR
$137B
$268K 0.1%
1,160
-137
-11% -$29.2K
BA icon
28
Boeing
BA
$171B
$267K 0.1%
+1,024
New +$219K
CMP icon
29
Compass Minerals
CMP
$1.23B
$257K 0.1%
10,139
-1,158
-10% -$29.6K
EQBK icon
30
Equity Bancshares
EQBK
$1.04B
$220K 0.08%
+6,486
New +$178K
AMZN icon
31
Amazon
AMZN
$2.92T
$209K 0.08%
+1,373
New +$192K
SHEL icon
32
Shell
SHEL
$254B
$208K 0.08%
3,163
+32
+1% +$2.1K
CFFN icon
33
Capitol Federal Financial
CFFN
$1.09B
$143K 0.05%
22,248
+352
+2% +$1.89K
POWW icon
34
Outdoor Holding Co
POWW
$249M
$42.8K 0.02%
20,375
PFE icon
35
Pfizer
PFE
$143B
-9,474
Closed -$314K

Similar funds

Triune Financial Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Triune Financial Partners held 35 positions worth $269M, up 11% from $243M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Triune Financial Partners's Q4 2023 filing shows 3 new, 17 increased, 10 reduced and 1 closed positions. Its largest new stake was Boeing: 1,024 shares worth $267K. The largest sale was Pfizer, an estimated $314K.

By sector, the portfolio is most concentrated in Financials at 1% of assets, up from 0.95% a quarter earlier, followed by Energy and Healthcare.

  • Triune Financial Partners's largest Q4 2023 buy was Boeing: 1,024 shares worth $267K.
  • Triune Financial Partners added most to Dimensional World ex US Core Equity 2 ETF in Q4 2023, an estimated $1.65M increase.
  • Triune Financial Partners's biggest Q4 2023 reduction was Eli Lilly, cutting an estimated $138K.
  • Triune Financial Partners fully exited Pfizer in Q4 2023, selling an estimated $314K.
  • Triune Financial Partners's ten largest holdings make up 97% of its $269M portfolio in Q4 2023.
  • Triune Financial Partners opened 3 new positions and closed 1 in Q4 2023.
  • Triune Financial Partners's portfolio value rose 11% quarter-over-quarter to $269M.

Based on Triune Financial Partners's 13F filing for Q4 2023, filed 14 Nov 2024.